These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5108379)

  • 21. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of various natural curares and d-tubocurarine retarding the coagulation time and prothrombin time of human blood].
    Canali J; Vieira J
    Mem Inst Oswaldo Cruz; 1967; 65(2):166-73. PubMed ID: 5619250
    [No Abstract]   [Full Text] [Related]  

  • 23. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias.
    Girolami A; Patrassi G; Toffanin F; Saggin L
    Am J Clin Pathol; 1980 Jul; 74(1):83-7. PubMed ID: 7395819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
    Goldschmidt B
    Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulant activities of some 2-acyl-1, 3-indandiones.
    Bond HW; Dedhiya MG; Carlson GP
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):288-91. PubMed ID: 4800265
    [No Abstract]   [Full Text] [Related]  

  • 26. Coagulation changes in isolated perfused lungs.
    Deysine M; Panossian A; Clarke RL; Cliffton EE; Veith FJ
    Vasc Dis; 1968 Jun; 5(2):70-7. PubMed ID: 5655303
    [No Abstract]   [Full Text] [Related]  

  • 27. [Laboratory control of the effect of anti-vitamins K on blood coagulation].
    Langer B; Muraco B; Manasterski J; Bechara MJ; Sitrângulo Júnior C; Puech-Leão LE
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(1):12-7. PubMed ID: 6484435
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the anticoagulant properties of 2 derivatives of 4-hydroxycoumarin].
    Thonnart N; Bourgain R; Reuse JJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):408-11. PubMed ID: 5031151
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of the blood clotting potential on the barrier function of the vessel wall.
    Schröer H; Hauck G
    Bibl Anat; 1969; 10():418-23. PubMed ID: 5407396
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 31. [Laboratory methods for the estimation of plasma clotting factors. Phase 2].
    Kagami M
    Rinsho Byori; 1969; 16():Suppl 16:85-92. PubMed ID: 5391589
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of several thromboplastins used to measure the one-stage prothrombin time.
    Littell AS; Ratnoff OD
    Thromb Diath Haemorrh Suppl; 1968; 35():135-48. PubMed ID: 5761061
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of a large dose of menaquinone-4 (K2) on the blood coagulation system in normal rabbits].
    Tajima T; Ogo T; Miyao K
    Nihon Yakurigaku Zasshi; 1971 Sep; 46(5):486-93. PubMed ID: 5168895
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of oral anticoagulant (marcumar) on prothrombin and related components in blood coagulation.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    Circ Res; 1957 May; 5(3):252-6. PubMed ID: 13427137
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma fibrinolytic activity associated with flurothyl induced convulsion.
    Cooper RG; Webb OL
    Thromb Diath Haemorrh; 1972 Dec; 28(3):376-82. PubMed ID: 4649272
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of oxalic and malonic acids on the clotting mechanism of dogs.
    Dooley KL; Zimmerman HE
    J Am Vet Med Assoc; 1971 Feb; 158(3):346-8. PubMed ID: 5545547
    [No Abstract]   [Full Text] [Related]  

  • 37. Bleeding mechanisms with special attention to coagulation disorders.
    Clin Pediatr (Phila); 1968 Jan; 7(1):34-42. PubMed ID: 5635217
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of injections of thrombin on blood coagulation and local haemostasis in rats.
    Lucas ON
    J Can Dent Assoc (Tor); 1968 Jul; 34(7):378-84. PubMed ID: 5302115
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on drug safety in gynecology. 2. On drug administration in advanced pregnancy].
    Krajnović P; Vranes N; Djurić N
    Arzneimittelforschung; 1974 Jul; 24(7):1063-6. PubMed ID: 4408116
    [No Abstract]   [Full Text] [Related]  

  • 40. Coumarin drug interactions.
    Kazmier FJ; Spittell JA
    Mayo Clin Proc; 1970 Apr; 45(4):249-55. PubMed ID: 5439135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.